U.S. Anti-snoring Devices And Snoring Surgery Market Size | Companies
The U.S. anti-snoring devices and snoring surgery market size was exhibited at USD 484.71 million in 2023 and is projected to hit around USD 918.45 million by 2033, growing at a CAGR of 6.6% during the forecast period of 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 516.70 Million |
| Market Size by 2033 | USD 918.45 Million |
| Growth Rate From 2024 to 2033 | CAGR of 6.6% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Type |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | U.S. |
| Key Companies Profiled | Ocular Therapeutix Inc.; SomnoMed Ltd.; Airway Management, Inc.; Resmed Inc.; Fisher & Paykel Healthcare Corp. Ltd.; Koninklijke Philips NV; Sleep Well Enjoy Life, Ltd.; Tomed Dr. Toussaint GmbH; MEDiTAS Ltd. |
The rising prevalence of obesity, the easy availability of products through offline and online channels in the U.S., and the launch of technologically advanced products are the major factors boosting the growth of the U.S. anti-snoring devices and snoring surgery market.
The COVID-19 pandemic had a major impact on the U.S. in every aspect, from healthcare to the economy, everything was severely affected. The pandemic led to a fall in sales of anti-snoring devices due to reduced patient visits to dentists. In addition, the lockdowns and restrictions on movement by the government severely disrupted the demand and supply chain which also contributed to a drop in sales of the devices during the pandemic.
Moreover, the pandemic also led to the postponement or cancellation of elective surgeries in order to avoid the spread of the virus. Many individuals also opted to willingly postpone their surgeries and avoid hospital visits, in order to avoid being infected with the virus. All these factors indicated that the pandemic had far-reaching effects on the industry. However, with the opening of economies and the world returning to normalcy, the market quickly gained traction and managed to recover at a very swift pace post-pandemic. Furthermore, with the launch of new products in the market, it is expected to grow exponentially over the forecast period as well.
Increasing prevalence of obesity is one of the major factors driving the demand for anti-snoring devices and snoring surgery devices. This is due to the increasing consumption of fast-food, and reduced physical activity which represents a growing shift towards a sedentary lifestyle among U.S. citizens. For instance, according to CDC, the U.S. obesity prevalence between the years 2021 to 2022 was 41.9%.
Obesity related problems include stroke, type 2 diabetes, heart disease, and certain types of cancer which are among the leading cause of premature preventable death. Additionally, the incidence of snoring and sleep apnea is also acute among individuals who are obese. In addition, the easy availability of these products in retail stores as well as through online sales is also a factor influencing the growth of the market. Moreover, the rise in the number of customers being inclined towards e-commerce and a wide variety of options on e-commerce sites is also helping the market to grow and will further accelerate over the forecast period.
Based on type, oral appliances/mouthpieces dominated the market with the highest market share in 2023. This is due to the growing adoption of these products among dentists and patients as it is the first line of treatment recommended for the treatment of snoring. Moreover, the launch of new products in the market with technologically advanced features is also driving the segment growth and leading to higher adoption of these products compared to other anti-snoring devices.
EPAP therapy devices is the second leading segment in terms of revenue in 2023. One of the main factors driving the growth of this segment is the launch of new products and the manufacturers' efforts to increase their sales by entering into a distribution agreement with strong regional distributors. In addition, the EPAP therapy device has shown tremendous potential in treating patients with snoring issues and obstructive sleep apnea which represents great growth for this segment over the forecast period as well.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. anti-snoring devices and snoring surgery market
Type
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Country scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in U.S.
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Country Outlook
2.3. Competitive Insights
Chapter 3. U.S. Anti - snoring Devices and Snoring Surgery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising geriatric and obese population
3.4.1.2. New product launches and regulatory approvals
3.4.1.3. Presence of huge patient pool
3.4.2. Market restraint analysis
3.4.2.1. High cost of surgeries
3.5. U.S. Anti - snoring Devices and Snoring Surgery Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. U.S. Anti - snoring Devices and Snoring Surgery Device: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Oral appliances/Mouthpieces
4.1.2. Nasal Devices
4.1.3. Position Control Devices
4.1.4. Chin Straps
4.1.5. Tongue Stabilizing Devices
4.1.6. EPAP Therapy Devices
4.2. Type Market Share, 2024 & 2033
4.3. Segment Dashboard
4.4. U.S. Anti - snoring Devices and Snoring Surgery Market by Type Outlook
4.5. Market Type & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5.1. Oral appliances/Mouthpieces
4.5.1.1. Market estimates and forecast 2021 - 2033
4.5.2. Nasal Devices
4.5.2.1. Market estimates and forecast, 2021 - 2033
4.5.3. Position Control Devices
4.5.3.1. Market estimates and forecast, 2021 - 2033
4.5.4. Chin Straps
4.5.4.1. Market estimates and forecast, 2021 - 2033
4.5.5. Tongue Stabilizing Devices
4.5.5.1. Market estimates and forecast, 2021 - 2033
4.5.6. EPAP Therapy Devices
4.5.6.1. Market estimates and forecast, 2021 - 2033
Chapter 5. U.S. Anti - snoring Devices and Snoring Surgery Market: Country Estimates & Trend Analysis
5.1. U.S. market share analysis, 2024 & 2033
5.2. U.S. Market Dashboard
5.3. U.S. Market Snapshot
5.4. U.S. Market Share and Leading Players, 2022
5.5. Market Application, & Forecasts and Trend Analysis, 2021 to 2033:
5.6. U.S.
5.6.1. Market estimates and forecast, 2021 - 2033
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Apnea Sciences Corporation
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Ocular Therapeutix, Inc.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. SomnoMed Ltd.
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Airway Management, Inc.
6.3.7.1. Financial performance
6.3.7.2. Product benchmarking
6.3.7.3. Strategic initiatives
6.3.8. Resmed Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Fisher & Paykel Healthcare Corp. Ltd.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Koninklijke Philips NV
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Sleep Well Enjoy Life, Ltd.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Tomed Dr. Toussaint GmbH
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. MEDiTAS Ltd.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers